Gan Y - Search Results

1

The cGAS/STING Pathway: A Novel Target for Cancer Therapy.

Gan Y, Li X, Han S, Liang Q, Ma X, Rong P, Wang W, Li W. Gan Y, et al. Front Immunol. 2022 Jan 3;12:795401. doi: 10.3389/fimmu.2021.795401. eCollection 2021. Front Immunol. 2022. PMID: 35046953 Free PMC article. Review.

2

Molecular imaging of tumor-associated macrophages in cancer immunotherapy.

Li X, Wang R, Zhang Y, Han S, Gan Y, Liang Q, Ma X, Rong P, Wang W, Li W. Li X, et al. Among authors: gan y. Ther Adv Med Oncol. 2022 Feb 26;14:17588359221076194. doi: 10.1177/17588359221076194. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35251314 Free PMC article. Review.

3

Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance.

Han S, Li X, Gan Y, Li W. Han S, et al. Among authors: gan y. Biomed Res Int. 2022 Mar 10;2022:5687832. doi: 10.1155/2022/5687832. eCollection 2022. Biomed Res Int. 2022. PMID: 35309168 Free PMC article.

4

The role of ubiquitination and deubiquitination in tumor invasion and metastasis.

Han S, Wang R, Zhang Y, Li X, Gan Y, Gao F, Rong P, Wang W, Li W. Han S, et al. Among authors: gan y. Int J Biol Sci. 2022 Mar 6;18(6):2292-2303. doi: 10.7150/ijbs.69411. eCollection 2022. Int J Biol Sci. 2022. PMID: 35414786 Free PMC article. Review.

5

Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis.

Ai J, Tan G, Li W, Liu H, Li T, Zhang G, Zhou Z, Gan Y. Ai J, et al. Among authors: gan y. Cell Biol Toxicol. 2023 Apr;39(2):537-556. doi: 10.1007/s10565-022-09738-w. Epub 2022 Jul 18. Cell Biol Toxicol. 2023. PMID: 35844005

6

Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance.

Dong X, Liu W, Li X, Gan Y, Zhou L, Li W, Xie L. Dong X, et al. Among authors: gan y. Sci Rep. 2022 Nov 30;12(1):20644. doi: 10.1038/s41598-022-21839-4. Sci Rep. 2022. PMID: 36450751 Free PMC article.

7

Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.

Li M, Gao F, Li X, Gan Y, Han S, Yu X, Liu H, Li W. Li M, et al. Among authors: gan y. Cell Death Dis. 2022 Dec 19;13(12):1053. doi: 10.1038/s41419-022-05500-6. Cell Death Dis. 2022. PMID: 36535926 Free PMC article.

8

Correction to: Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.

Li M, Gao F, Li X, Gan Y, Han S, Yu X, Liu H, Li W. Li M, et al. Among authors: gan y. Cell Death Dis. 2023 Jan 18;14(1):36. doi: 10.1038/s41419-022-05533-x. Cell Death Dis. 2023. PMID: 36653350 Free PMC article. No abstract available.

9

Artificial intelligence assists precision medicine in cancer treatment.

Liao J, Li X, Gan Y, Han S, Rong P, Wang W, Li W, Zhou L. Liao J, et al. Among authors: gan y. Front Oncol. 2023 Jan 4;12:998222. doi: 10.3389/fonc.2022.998222. eCollection 2022. Front Oncol. 2023. PMID: 36686757 Free PMC article. Review.

10

Author Correction: Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance.

Dong X, Liu W, Li X, Gan Y, Zhou L, Li W, Xie L. Dong X, et al. Among authors: gan y. Sci Rep. 2023 Jan 31;13(1):1780. doi: 10.1038/s41598-023-28989-z. Sci Rep. 2023. PMID: 36720899 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,990 results

Search Page

Filters